45-1
45th Parliament,
1st Session
(May 26, 2025 - Present)
Select a different session
Meeting Detail
Thursday, September 24, 2026
Partial In Camera
10:30 a.m. ET
Location:
Room B45, Senate of Canada Building, 2 Rideau Street, Ottawa ON, with videoconference
Clerk:
Ferda Simpson
(613) 698-0113
The subject matter of those elements contained in Divisions 9 and 12 of Part 4 of Bill C-31, Budget 2025 Implementation Act, No. 2
Topic:
Part 4, Division 12 (Tobacco and Vaping Products)
Consideration of a draft report
Witnesses
- Dr. Alexander Caudarella, Chief Executive Officer (Canadian Centre on Substance Use and Addiction)
- Rob Cunningham, Senior Policy Analyst (Canadian Cancer Society)
- Daniel David, Vice President (Canadian Vaping Association)
- Danny Fournier, Director, Illicit Trade Prevention (Rothmans, Benson & Hedges Inc.)
- Pascal Michel, Director, Scientific Engagement (Rothmans, Benson & Hedges Inc.)
- Foram Patel, Senior Specialist, Policy (Heart and Stroke Foundation)
- Helena Sonea, Director, Advocacy (Canadian Cancer Society)
Meeting with interpretation and transcription